Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 51 | 5 | 3,087 | 29 | 7 |
| Gross Profit | 51 | 5 | 3,087 | 29 | 7 |
| Operating Expenses | 3,917 | 2,326 | 2,846 | 1,492 | 952 |
| Operating Income | -3,866 | -2,321 | 241 | -1,463 | -945 |
| Interest Expense | 307 | 186 | 264 | 100 | 108 |
| Other Income | 9,350 | -12,508 | 1,074 | 3,315 | 1,861 |
| Pre-tax Income | 5,177 | -15,015 | 1,051 | 1,752 | 808 |
| Net Income Continuous | 5,177 | -15,015 | 1,051 | 1,752 | 808 |
| Minority Interests | -27 | N/A | N/A | N/A | N/A |
| Net Income | $5,204 | $-15,015 | $1,051 | $1,752 | $808 |
| EPS Basic Total Ops | 0.61 | -5.38 | 0.42 | 0.80 | 0.37 |
| EPS Basic Continuous Ops | 0.61 | -5.38 | 0.42 | 0.80 | 0.37 |
| EPS Diluted Total Ops | 0.51 | -5.38 | 0.19 | 0.23 | 0.11 |
| EPS Diluted Continuous Ops | 0.51 | -5.38 | 0.18 | 0.23 | 0.11 |
| EPS Diluted Before Non-Recurring Items | 0.51 | -3.38 | N/A | N/A | N/A |
| EBITDA(a) | $-3,502 | $-2,274 | $247 | $-1,409 | $-928 |